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Abstract
Background: Most mental disorders first emerge in youth and, in their early stages, surface as subthreshold expressions of
symptoms comprising a transdiagnostic phenotype of psychosis, mania, depression, and anxiety. Elevated stress reactivity is one
of the most widely studied mechanisms underlying psychotic and affective mental health problems. Thus, targeting stress reactivity
in youth is a promising indicated and translational preventive strategy for adverse mental health outcomes that could develop
later in life and for improving resilience. Compassion-focused interventions offer a wide range of innovative therapeutic techniques
that are particularly amenable to being implemented as ecological momentary interventions (EMIs), a specific type of mobile
health intervention, to enable youth to access interventions in a given moment and context in daily life. This approach may bridge
the current gap in youth mental health care.
Objective: This study aims to investigate the clinical feasibility, candidate underlying mechanisms, and initial signals of the
efficacy of a novel, transdiagnostic, hybrid EMI for improving resilience to stress in youth—EMIcompass.
Methods: In an exploratory randomized controlled trial, youth aged between 14 and 25 years with current distress, a broad
Clinical High At-Risk Mental State, or the first episode of a severe mental disorder will be randomly allocated to the EMIcompass
intervention (ie, EMI plus face-to-face training sessions) in addition to treatment as usual or a control condition of treatment as
usual only. Primary (stress reactivity) and secondary candidate mechanisms (resilience, interpersonal sensitivity, threat anticipation,
negative affective appraisals, and momentary physiological markers of stress reactivity), as well as primary (psychological distress)
and secondary outcomes (primary psychiatric symptoms and general psychopathology), will be assessed at baseline, postintervention,
and at the 4-week follow-up.
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Results: The first enrollment was in August 2019, and as of May 2021, enrollment and randomization was completed (N=92).
We expect data collection to be completed by August 2021.
Conclusions: This study is the first to establish feasibility, evidence on underlying mechanisms, and preliminary signals of the
efficacy of a compassion-focused EMI in youth. If successful, a confirmatory randomized controlled trial will be warranted.
Overall, our approach has the potential to significantly advance preventive interventions in youth mental health provision.
Tr i a l  R e g i s t r a t i o n :  G e r m a n  C l i n i c a l  Tr i a l s  R e g i s t e r  D R K S 0 0 0 1 7 2 6 5 ;
https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00017265
International Registered Report Identifier (IRRID): DERR1-10.2196/27462
(JMIR Res Protoc 2021;10(12):e27462) doi: 10.2196/27462
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Introduction
Background
Youth is a critical life period, and most mental disorders have
their onset before the age of 25 years [1]. In the early stages of
psychopathology, subthreshold expressions of symptoms may
occur, reflecting an extended phenotype in the general
population that is often transdiagnostic in nature, spanning from
subthreshold expressions of anxiety, depression, and mania to
psychotic experiences [2-4]. This extended transdiagnostic
phenotype may, in turn, be associated with a range of subsequent
psychopathological outcomes or exit syndromes later in life
[2,3]. On the basis of emerging evidence on the transdiagnostic
dimensions of psychopathology [5-10], dimensional
classification systems with transdiagnostic high-order spectra
that place individuals on a continuum of mental ill-health have
recently been proposed, including the Hierarchical Taxonomy
of Psychopathology [11-14], and clinical staging models have
been proposed considering the overlapping and nonspecific
nature of early psychopathology [15-18]. For example,
Hartmann et al [16] in their clinical staging model, distinguish
three stages of early mental health problems, that is, current
psychological distress (stage 1a), a broad Clinical High At-Risk
Mental State (CHARMS) with attenuated symptoms of
psychosis, mania, or depression (stage 1b), and a first episode
of severe mental disorder (stage 2). Moreover, mental disorders
in youth aged 10-24 years have been reported to be the leading
cause of disease burden in high-income countries [19],
underlining the importance of early intervention and prevention.
However, access to care remains deficient, with only 1 in 5
youth with mental health problems having access to mental
health services [20,21]. Thus, there is a strong need for easily
accessible, low-threshold, preventive interventions in the
provision of youth mental health services.
Recent rapid advances in digital technologies have led to the
development of novel mobile health (mHealth) assessment and
intervention techniques, of which ecological momentary
assessments (EMAs) [22,23] and ecological momentary
interventions (EMIs) [23-28] are, arguably, among the most
powerful [26,28]. EMIs such as Acceptance and Commitment
Therapy in Daily Life [29,30], recently also referred to as
just-in-time adaptive interventions [31], provide a unique
opportunity to deliver youth-friendly, adaptive, personalized,
real-time transfer of intervention components to individuals’
daily lives. EMIs enable youth to access interventions tailored
to what a young person needs in a given moment and context
through interactive sampling and administration of specific
training components [26,27,32]. To this end, EMIs build on
real-time data acquired through EMA, a structured digital diary
technique that measures moment-to-moment fluctuations in
experience, behavior, and—when coupled with
electrocardiography (ECG) and actigraphy
sensors—physiological markers in daily life to offer training
components that are adapted to the person, moment, and context
based on EMA data. Therefore, EMIs are amenable to enhancing
access to mental health services for youth depending on their
needs and preferences. Indeed, youth—as the generation of
digital natives—already make regular use of mHealth apps and
are more likely to do so when experiencing psychological
distress [33]. However, most mHealth apps that are currently
available in major app stores are not evidence-based, often use
problematic data sharing and privacy practices, and sometimes
contain harmful content [34-36]. As reviewed recently, there is
evidence on the effectiveness of mindfulness-based EMI for
stress reduction [37] and reduction of psychotic experiences
[30,38,39]. Furthermore, there is evidence for higher compliance
and greater effectiveness of hybrid interventions that include
both digital and face-to-face intervention components with
research staff or clinicians [40,41].
Underlying transdiagnostic mechanisms may be important
intervention targets in youth to prevent transition to and
incidence of severe mental disorder. The most widely studied
transdiagnostic mechanisms are (1) elevated stress reactivity
(ie, more intense emotional reactions to minor stressors in daily
life), (2) heightened interpersonal sensitivity, and (3) enhanced
threat anticipation. There is evidence that stress reactivity is
elevated in individuals with higher familial or psychometric
risk, individuals with an ultrahigh risk state for psychosis,
first-episode psychosis, severe and enduring psychosis [42-45],
as well as with depressive disorder [46-48], mania, and bipolar
disorder [49-51]. Moreover, some evidence suggests that
differential reactivity to momentary stressors may reflect a risk
and resilience mechanism [44,52-54]. Heightened interpersonal
sensitivity is another putative transdiagnostic psychological
mechanism that has been characterized by an enduring sense
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of feeling vulnerable in the presence of others [43,55].
Interpersonal sensitivity has been previously reported as a
relevant psychological mechanism in individuals with ultrahigh
risk, paranoia, and psychotic disorders [55,56] as well as in
individuals with affective disturbances, including depression,
anxiety, and bipolar disorder [57-59].
Furthermore, our recent EMA findings extended beyond
elevated interpersonal and socioenvironmental sensitivity and,
consistent with previous research on psychotic, depressive, and
anxiety disorders [60-65], also indicated that enhanced
anticipation of threat might be an important mechanism in the
development of psychosis [43,44]. These mechanisms have
been implicated in a range of adverse mental health outcomes,
which we have found to overlap considerably [2,5,6,66] and,
as noted above, often manifest at a developmentally early stage
in adolescence. Thus, developing EMIs targeting these candidate
mechanisms underlying a dimensional transdiagnostic and
extended phenotype of psychosis, mania, depression, and anxiety
in youth is a promising indicated strategy [67] for preventing
transition to, and incidence of, severe mental disorders, which,
if effective, will be associated with substantial public health
gains.
Compassion-focused interventions are third-wave cognitive
behavioral therapy (CBT) approaches that use a wide range of
innovative therapeutic techniques for enhancing emotional
resilience by activating emotion regulation systems related to
self-compassion, self-acceptance, and positive affect rather than
those related to stress, threat, anxiety, and depression [68-70].
Indeed, there is meta-analytic evidence on compassion-focused
interventions treating various conditions [71-73], such as
depression and anxiety [74], psychosis [75], and general distress
[76]. Compassion-focused interventions involve the use of
techniques that seek to access emotion regulation processes
through imagery rather than rational understanding [68,69]. In
doing so, compassion-focused interventions aim to enhance
emotional resilience by developing specific affective regulation
patterns and, thereby, reduce reactivity to stress, hypervigilance
for threat, interpersonal sensitivity, and negative affective
appraisals. Experimental evidence indicates that
compassion-focused intervention techniques can reduce negative
affect and paranoia in moments of high stress [77,78]. Therefore,
compassion-focused interventions are particularly promising
for targeting these putative transdiagnostic mechanisms.
Building on these pieces of evidence, we have recently
developed a novel, accessible, transdiagnostic,
compassion-focused, hybrid intervention to enhance resilience
in youth with early mental health problems—the EMIcompass
intervention [53], which consists of an EMI plus face-to-face
training sessions. Although there is preliminary evidence on
the feasibility and initial therapeutic effects of the EMIcompass
intervention from an uncontrolled pilot study [53], robust
evidence on the underlying mechanisms, feasibility, and initial
signals of efficacy of EMIcompass from an exploratory trial is
pending.
Objectives
Against this background, this study will aim to examine the
clinical feasibility, underlying mechanisms, and initial signals
of efficacy of EMIcompass for improving resilience in an
exploratory, randomized controlled trial (RCT) of youth with
current psychological distress, a broad CHARMS, or a first
episode of severe mental disorder. The EMIcompass intervention
will be administered in addition to treatment as usual (TAU) in
the experimental condition compared with a control condition
of TAU only. Specifically, this study’s aims are as follow:
1. to establish the clinical feasibility of the trial methodology
and deliver the EMIcompass intervention to youth with
early mental health problems (based on successful
recruitment, assessment of inclusion criteria, randomization,
retention in the assessment of outcomes, fidelity of
delivering the intervention, compliance with the intervention
protocol, satisfaction, and acceptability);
2. to detect initial signals of the efficacy of the EMIcompass
intervention in reducing psychological distress (candidate
primary outcome), primary (ie, psychotic, manic, anxiety,
or depressive) symptoms, and general psychopathology
(candidate secondary outcomes) at postintervention and
4-week follow-up;
3. to test the effects of the EMIcompass intervention on
reducing stress reactivity (primary candidate mechanism),
threat anticipation, interpersonal sensitivity, negative
affective appraisals, resilience, self-compassion, emotion
regulation, and physiological markers of stress reactivity
(secondary candidate mechanisms) at postintervention and
4-week follow-up; and
4. to explore whether the effects of the EMIcompass
intervention on psychological distress, primary (ie,
psychotic, manic, anxiety, or depressive) symptoms, and
general psychopathology are mediated via pathways through
stress reactivity, threat anticipation, interpersonal sensitivity,




In an exploratory RCT, youth aged 14-25 years will be randomly
assigned to the EMIcompass intervention in addition to TAU
(experimental condition) or a control condition of TAU only,
which will include routine mental health care. Participants will
be recruited from mental health services in Mannheim,
Germany, and via advertisements on the institute’s webpage,
Facebook, and Instagram and via local registries. Candidate
mechanisms and outcomes will be assessed before
randomization (at baseline), at the end of the 6-week
intervention period (postintervention), and at the 4-week
follow-up (ie, 4 weeks after completing the intervention period)
by blinded assessors (Figure 1). Randomization will be
conducted by an independent researcher using a
computer-generated sequence. The assessment of outcomes and
statistical analyses will be blinded to the treatment allocation.
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Figure 1. Study flowchart. EMA: ecological momentary assessment, collected eight times per day on 6 consecutive days (including self-reported and
activity or electrocardiography sensor); n denotes the total number of participants.
Participants
We will recruit and randomize 92 individuals with current
psychological distress, CHARMS or a first episode of severe
mental disorder based on a modified version of the clinical
staging model by Hartmann et al [16]. Individuals presenting
to mental health services at the Central Institute of Mental
Health (CIMH), Mannheim, will be approached by a clinician
who will provide initial information about the study. If the
individual agrees, their treating clinician will pass on their
contact details to the research team. In addition, individuals
from the general population, who do not seek help from mental
health services at CIMH, will be recruited for example, via
social media or local registries. All participants will then be
contacted by the research team, and initial information about
the study will be provided. Following this, individuals will be
fully informed about the study, and written informed consent
will be obtained by researchers with a master’s degree in
psychology (including parents or legal guardians for minors),
which can be withdrawn at any time without any negative
consequences. Eligibility will then be assessed in an interview
using observer-rated measures (Structured Clinical Interview
for Diagnostic and Statistical Manual of Mental Disorders, fifth
edition (DSM-5) [79]; Comprehensive Assessment of At-Risk
Mental State [80] completed by the researcher; and self-reported
measures using the Kessler Psychological Distress Scale [1,81]).
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All participants will be reimbursed for their time and travel
expenses at the end of the study.
Ethics Approval and Consent to Participate
The study, titled Efficacy of a novel, accessible, transdiagnostic,
compassion-focused ecological momentary intervention for
help-seeking youth (EMIcompass), has received ethical approval
from the local ethics committee of the Medical Faculty
Mannheim Heidelberg University (2017-602N-MA, date:
September 7, 2017). Ethical approval was granted before
funding was obtained, given that this is a requirement for project
grants by the German Research Foundation. All participants
and, in the case of individuals aged <18 years, parents or legal
guardians will provide written informed consent before inclusion
in the study. The sponsor has an insurance, which covers
accidents on the journeys to the study appointments. However,
no insurance covers harm from study participation, as this is
expected to be of low risk.
Inclusion and Exclusion Criteria
Textbox 1 provides an overview on the inclusion and exclusion
criteria, and Table 1 defines the inclusion criteria in more detail.
Textbox 1. Inclusion and exclusion criteria.
Inclusion criteria
• Age between 14 and 25 years
• Meeting criteria for one of the following stages (based on a modified version of the clinical staging model by Hartmann and colleagues [16]):
individuals with current psychological distress (stage 1a), that is, a score of 20 or above on the Kessler Psychological Distress Scale [1,81], but
no Clinical High At-Risk Mental State (stage 1b) or first episode of severe mental disorder (stage 2); individuals who meet criteria for a Clinical
High At-Risk Mental State (stage 1b); individuals, who meet criteria for a first episode of psychotic disorder, bipolar disorder, severe depressive
disorder or severe anxiety disorder according to according to the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5)
(stage 2)
• High emotional reactivity assessed with a two-item self-report measure (instruction: “Please think of the most unpleasant event in the last week:
(1) How sad, disappointed or angry have you been? (2) Have you been sad, disappointed or angry because of your feelings?”) rated on a 7-point
Likert scale (ie, a score of ≥3 indicating high reactivity) or by the interviewer-rated Comprehensive Assessment of At-Risk Mental State subscale
[80] rated on a 7-point Likert scale (ie, with a rating of ≥3 indicating high reactivity)
• Reduced positive affect (ie, a mean positive affect score below 3.19 for men and 3.05 for women based on normative scores from a representative
sample of the German population [82]) or increased negative affect (ie, a mean negative affect score above 1.81 for men and 1.75 for women
[82]) assessed using the Positive Affect and Negative Affect Scale [83]
• Willingness to participate in the EMIcompass intervention
• Ability to provide written informed consent (or consent by parents in the case of minors)
Exclusion criteria
• A primary diagnosis of alcohol or substance abuse or dependence, assessed using the Structured Clinical Interview for DSM-5 [79]
• Evidence that symptoms are precipitated by an organic disease
• Insufficient command of German so that the intervention cannot be followed, and outcomes cannot be reasonably assessed in German
• Diagnosis of a learning disability according to case records
• Current suicidal ideation (indicated by a score>4 in the Comprehensive Assessment of At-Risk Mental State [80])
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Table 1. Inclusion criteria and transdiagnostic sample characteristics based on a modified version of the clinical staging model by Hartmann et al [16].
MeasureStage and criteria
1a (distressed individuals)
• K10• Psychological distress (K10a score ≥20) but not fulfilling criteria of stage 1b or 2
1b (CHARMSb)
Psychosis trait vulnerability
• Family risk• First degree relative with psychosis and SOFASc < 50 in the last 12 months or
• SOFAS• Or SOFAS 30% below the past level
Psychosis trait vulnerability
• SCID IId• Schizotypal personality and SOFAS <50 in the last 12 months or
• Or SOFAS 30% below the past level • SOFAS
Bipolar trait vulnerability
• SCID-5e• Depressed mood or diminished interest or pleasure for at least 1 week as well as two addi-
tional criteria of depression: weight loss, sleep disorder, psychomotor disturbances, loss • Family risk
of energy, feelings of worthlessness or guilt, diminished ability to think or concentrate or
indecisiveness, suicidality
• And mood swings for at least 6 months in the lifetime (not symptom-free for a longer pe-
riod than 2 months consecutively) and at least three symptoms: decreased need for sleep,
increased energy, inflated self-esteem or grandiosity, increase in goal-directed activity,
restlessness, increased talkativeness, unusual ideas, risky behavior, inappropriate humor
(does not have to equal loss of function!)
• Or first degree relative with bipolar disorder
Attenuated psychotic symptoms
• CAARMS• CAARMSf global rating score of 3-6 and frequency of 3-6 on the subscales: unusual
thought content, nonbizarre ideas, perceptual abnormalities, disorganized speech
• Or global rating score of 6 and frequency of 3 on the subscales: unusual thought content,
nonbizarre ideas, perceptual abnormalities, disorganized speech
Attenuated hypomanic symptoms
• CAARMS• Elevated, expansive or unusually irritable mood on at least 2 consecutive days
• And 2 (or in case of only irritable mood 3) additional criteria: inflated self-esteem or
grandiosity, decreased need for sleep, increased talkativeness, flight of ideas or subjective
experience that thoughts are racing, distractibility, increase in goal-directed activity or
psychomotor agitation, unusual ideas, increased involvement in activities that are pleasur-
able in short time but have a high potential for long-term damage
• For a duration of 3 days maximum if 3 or more (or in case of only irritable mood 4 or
more) additional criteria are met and there are functional disturbances or others notice the
mood or functional disturbances
• For a duration of 6 days maximum if 3 or more (or in case of only irritable mood 4 or
more) additional criteria are met or there are functional disturbances or others notice the
mood or functional disturbances
• Exclusion: hospitalization, severe impairment in social or professional functioning, no
psychotic elements
Moderate (attenuated) depression
• SCID-5• Mild or moderate depression (current or lifetime), that is, at least 1 cardinal symptom, 5
additional symptoms • HAM-D
• And HAM-Dg>17 (cutoff)
BLIPSh
• CAARMS• Global rating of 6 on the subscales: unusual thought content or nonbizarre ideas
• Or global rating of 5 or 6 on the subscale perceptual abnormalities
• And/or global rating of 6 on the subscale disorganized speech present for less than a week
• And frequency of 4-6 on all above mentioned scales
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• Mild or moderate panic disorder /agoraphobia (current or lifetime)
• Or not fully meeting criteria for GADi, that is, symptoms for less than 6 months or less
than four symptoms met
• Or mild or moderate social phobia (current or lifetime)
• And HAM-Aj>9 (cutoff)
2 (first treated episode)
CAARMSPsychosis
SCID-5Severe major depression (current or lifetime)
SCID-5Mania or hypomania
SCID-5Severe anxiety disorder (current or lifetime); eg, agoraphobia, GAD
aK10: Kessler Distress Scale [81].
bCHARMS: Clinical High At-Risk Mental State.
cSOFAS: Social and Occupational Functioning Assessment Scale [84].
dSCID II: Structured Clinical Interview for DSM-IV Axis II Personality Disorders,
eSCID-5: Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5) [79].
fCAARMS: Comprehensive Assessment of At-Risk Mental State [80].
gHAM-D: Hamilton Depression Rating Scale [85].
hBLIPS: brief limited intermittent psychotic symptoms.
iGAD: Generalized Anxiety Disorder.
jHAM-A: Hamilton Anxiety Rating Scale [86].
Interventions
Control Condition: TAU
Participants allocated to the TAU control condition will continue
to receive all the treatment they received before the start of the
study. This will include good standard care delivered according
to local and national service guidelines and protocols by their
general practitioner, psychiatrist, and other providers of (mental)
health care. Service contacts will be assessed for the duration
of the trial using the Client Service Receipt Inventory [87] to
monitor variation in the delivery of, and engagement with,
mental health services.
Experimental Condition: EMIcompass Intervention Plus
TAU
The EMIcompass intervention will be delivered by trained
psychologists within a 6-week period in addition to TAU to
individuals allocated to the experimental condition. TAU
consists of all the treatment individuals received before inclusion
in the study, including their general practitioner, psychiatrist,
and clinical psychologist, except for treatment using elements
of third-wave CBT. The manualized EMIcompass intervention
consists of four biweekly sessions (three training sessions and
one review session) with a duration of 45-60 minutes
administered face-to-face or using a certified and encrypted
video conferencing system and a 6-week compassion-focused
EMI. An optional on-demand session will be offered if
participants are unable to complete tasks between sessions or
report acute psychological distress so that a scheduled session
cannot be followed as per the manual. The EMI, which translates
the training from the intervention sessions into individuals’
daily lives, will be administered through a smartphone-based
app (movisensXS, movisens GmbH) running on dedicated study
smartphones. The first three sessions are based on elements of
compassion-focused therapy [68]. In line with our pilot study
[53], compassion-focused therapy principles and techniques are
introduced in these guided sessions. The first session aims to
familiarize the participants with the app offering EMI. Further,
practical tasks to activate the soothing system, as a key emotion
regulation system in compassion-focused therapy, are presented
and trained together with the psychologist, as described
elsewhere [88]. Face-to-face sessions also offer the opportunity
to reflect on the progress and problems participants face with
EMI. In the last session, progress with all tasks will be reviewed
and subjective improvement in, compliance and satisfaction,
and acceptance of the EMIcompass intervention will be assessed.
The app will offer EMI tasks according to three types of delivery
schemes: (1) enhancing, (2) consolidating, and (3) interactive
EMI tasks that aim for ecological translation of therapeutic
principles and techniques to daily life. Participants will be asked
to complete one enhancing task per week, practicing new
compassion-focused tasks such as self-compassionate writing,
experiencing emotions as a wave, and discovering their own
compassionate self. Furthermore, participants will be offered
consolidating tasks covering components of enhancing tasks
from previous days. The components of consolidating tasks
will be extended each time an enhancing task has been presented
until all components are covered. In addition, participants will
be offered to complete a brief EMA of momentary stress,
affective disturbance, and threat anticipation six times per day,
3 days per week. On the basis of these EMAs, interactive tasks
will be offered if participants score high on momentary stress
or negative affect. The threshold for triggering interactive tasks
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will be either high momentary negative affect operationalized
as a score of 4 or higher (on a 7-point Likert scale ranging from
1-7) on items of established and validated EMA measures of
negative affect (Textbox 2) or high momentary stress based on
items of established and validated measures of EMA of
event-related, activity-related, or social stress (ie, a score <0 on
a bipolar scale ranging from −3 to 3).
Participants will be instructed in detail in the semantic meaning
of the 7-point Likert and bipolar scales and encouraged to
carefully observe moment-to-moment variation in, and make
use of the full range when rating, these scales on EMA items
that have been previously used and validated to measure
moment-to-moment variation in stress or negative affect. Given
that a crucial element of compassion-focused therapy is for
individuals to use compassionate imagery in moments of high
stress or negative affect, these interactive tasks reflect an
important component of the EMIcompass intervention.
Participants can decline the EMI tasks in each delivery scheme.
After completing the intervention period, participants will return
the study devices and will no longer have access to the app.
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Textbox 2. Ecological momentary assessment domains and measures.
Momentary stress
Momentary stress was operationalized as unpleasant events, activities, and social situations in daily life. In line with previous research, we distinguished
three different types of stress, that is, event-related stress, activity-related stress, and social stress [43,89]. Participants will be asked to report the most
important event that happened in the time since the last assessment. This event will be subsequently rated on a 7-point Likert scale (−3=very unpleasant,
0=neutral, 3=very pleasant) comprising the event-related stress measure. Activity-related stress will be assessed by asking participants to report their
current activity and then judge the valence of the activity (“This is...”) using a 7-point Likert scale (1=very unpleasant, 7=very pleasant). Further,
social stress will be measured by asking participants to evaluate the social context when other people were present as well as when they were alone
by answering the items “I am taking care of myself”/“I am taking care of somebody” and “I would rather be alone”/“I would prefer to have company”
using two 7-point Likert scales and the item on social valence (“This is...” rated on the 7-point Likert scale from 1=very unpleasant to 7=very pleasant)
Negative affect
Six items will be used to assess negative affect (anxiousness, loneliness, insecurity, anger, annoyance, and feeling down), using 7-point Likert scales
ranging from “not at all” (rating of 1) to “very much” (rating of 7)
Negative affective appraisals
In case participants report negative affect (ratings >3), two items on how they cope with their negative affect will be displayed: “I want to change my
negative feelings” and “I would like to get rid of my negative feelings” using two 7-point Likert scales
Positive affect
Positive affect will be assessed by four items (cheerfulness, satisfaction, enthusiasm, and feeling relaxed) using 7-point Likert scales ranging from
“not at all” (rating of 1) to “very much” (rating of 7)
Aberrant salience
The ecological momentary assessment measure comprises three items in line with [43]. The items will be rated on a 7-point Likert scale (ranging from
1 [“not at all”] to 7 [“very much”]): “Everything grabs my attention right now,” “Everything seems to have meaning right now,” and “I notice things
that I haven’t noticed before”
Self-esteem
Three items will be rated on a 7-point Likert scale ranging from “not at all” (rating of 1) to “very much” (rating of 7): “I feel guilty,” “I doubt myself,”
“I feel disappointed about myself”
Self-compassion
Three items will be rated on a 7-point Likert scale ranging from “not at all” (rating of 1) to “very much” (rating of 7): “I like myself,” “I feel safe,”
“I feel benevolent”
Psychotic experiences
Psychotic experiences will be assessed using eight items on thought problems and hallucinations (“I see things that aren’t really there,” “I hear things
that aren’t really there,” “I feel suspicious,” “It's hard to express my thoughts in words,” “I feel unreal,” “My thoughts are influenced by others,” “I
can’t get these thoughts out of my head,” “I feel like I am losing control”) that will be rated on 7-point Likert scales ranging from “not at all” (rating
of 1) to “very much” (rating of 7)
Resilience
If participants indicate that there was a negative event (valence −3 or −2), then the item “I had difficulties to recover” will be rated on a 7-point Likert
scale
Threat anticipation
In line with previous research, we will ask participants to rate the likelihood of negative events happening to them in the future [43]. They will be
asked to think of what might happen in the next few hours and to rate the item “I think that something unpleasant will happen” on a 7-point Likert
scale from “not at all” (rating of 1) to “very much” (rating of 7)
Disturbance
“This prompt disturbed me” will be rated at the end of each assessment on a 7-point Likert scale from “not at all” (rating of 1) to “very much” (rating
of 7)
Clinical Feasibility, Acceptability, Treatment
Adherence, and Intervention Fidelity
Clinical feasibility will be assessed in relation to the trial
methodology and the delivery of the EMIcompass intervention
to youth with early mental health problems. The feasibility of
the trial methodology will be assessed based on the following
criteria: (1) successful recruitment of at least 96 participants
during the study period; (2) assessment of inclusion criteria in
95% of potential participants after obtaining written consent;
(3) successful randomization of at least 92 participants after
completion of eligibility and baseline assessment; and (4) a
retention rate of at least 85% for assessment of outcomes at
least at one of the two time points at postintervention and 4-week
follow-up. In addition, the following criteria will be used for
establishing the feasibility of delivering the EMIcompass
intervention, including its acceptability, intervention adherence,
and intervention fidelity: (1) satisfaction with the EMIcompass
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intervention in general, ease of use, accessibility and
comprehensiveness of various components of the intervention
in a debriefing questionnaire [30,90], and the subjective quality
of EMIcompass using the mobile application rating scale [91];
(2) compliance with, and adherence to, the EMIcompass
intervention protocol based on a satisfactory level of session
attendance, an adherence checklist covering all core components
[29,30,92], and adherence to EMI tasks (ie, mean number of
consolidating/interactive EMI tasks completed per week); and
(3) fidelity to the EMIcompass intervention protocol based on
independent ratings of a random selection of audio recordings
of three face-to-face sessions, including fidelity to session
protocol (ie, independent rating of core components delivered
by trained psychologist), ability to model and embody the spirit
of compassion, and the use of microskills in compassion-focused
therapy assessed by the Compassion Focused Therapy-Therapist
Competence Rating Scale [93].
Candidate Mechanisms and Outcomes
Overview
After obtaining written informed consent, all eligible participants
will be assessed on candidate mechanisms and outcomes before
randomization (baseline, t0), after the 6-week intervention period
(postintervention, t1) and after a 4-week follow-up period
(follow-up, t2) by blinded assessors (Figure 1 and Multimedia
Appendix 1). Research Electronic Data Capture (REDCap) [94],
a secure, web-based software platform hosted at the CIMH
servers, will be used for data collection.
Primary Candidate Mechanism
The primary candidate mechanism is a reduction in stress
reactivity acquired by EMA from baseline to postintervention
for the experimental condition compared with the control
condition. EMA will include eight assessments per day,
scheduled at random within set blocks of time, for 6 consecutive
days at baseline, postintervention, and follow-up [43,95].
Momentary stress will be assessed using established and
validated EMA measures of event-related stress, activity-related
stress, and social stress (Textbox 2) [43,89]. We will compute
a composite momentary stress measure (ie, the mean score of
event-related, activity-related, and social stress) in line with the
literature [52,96,97] and the EMIcompass pilot study [53].
Negative affect will be assessed using an established and
validated EMA measure of negative affect [43]. Stress reactivity
as the primary candidate mechanism will be computed in linear
mixed models with composite momentary stress as the
independent variable and negative affect as the outcome variable
[43,89,95].
Secondary Candidate Mechanisms
Secondary candidate mechanisms (Multimedia Appendix 1 and
Textbox 2) measured using EMA include threat anticipation,
negative affective appraisals, emotional resilience to stress
(operationalized as attenuated recovery in positive affect in
response to minor stressors), and elevated stress reactivity (ie,
increased negative affect) in response to event-related,
activity-related, and social stress using subscale scores of the
EMA stress measure. Threat anticipation will be additionally
assessed using the Threat Anticipation Measure [62], asking
participants to estimate the future likelihood of a list of negative,
neutral, and positive events happening to themselves and other
people [61-63]. Interpersonal sensitivity will be assessed using
the Interpersonal Sensitivity Measure [98] in addition to EMA.
Resilience will be measured using the Connor-Davidson
Resilience Scale [99] and the Resilience Scale [100].
Furthermore, the Self-Compassion Scale [101], the Fife Facet
Mindfulness Questionnaire [102], and the Cognitive Emotion
Regulation Questionnaire [103] will be used to assess
self-compassion and emotion regulation. In addition, we will
assess physiological markers of stress reactivity using a sensor
for ambulatory ECG and actigraphy (movisens ECGmove4)
during the 6-day EMA at baseline, postintervention, and at
follow-up.
Candidate Primary Outcome
The candidate primary outcome of this exploratory RCT is
psychological distress measured using the well-validated Kessler
Psychological Distress Scale [81]. The 10 items are rated on a
1 (never) to 5 (always) Likert scale focusing on psychological
distress in the last month. Strong psychometric properties have
been reported with a reliability of Cronbach α>.90 [81].
Candidate Secondary Outcomes
Secondary outcomes include primary (ie, psychotic, manic,
anxiety, or depressive) symptoms and general psychopathology.
These will be assessed using the following observer-rated
measures: the Brief Psychiatric Rating Scale [104], including
the Comprehensive Assessment of At-Risk Mental State [80],
the Young Mania Rating Scale [105], the Hamilton Depression
Rating Scale [85] and the Hamilton Anxiety Rating Scale [86].
On the basis of these measures, we will assess the transition to
another clinical stage (according to a modified version of the
clinical staging model by Hartmann et al [16]; see above). In
addition, the following self-report measures will be used: the
Brief Symptom Inventory [106], the Beck Depression Inventory
[107], and the Prodromal Questionnaire [108]. Secondary
outcomes further include quality of life measured using the
WHO-Quality of Life assessment [109].
Other Measures
Other study parameters will include basic sociodemographic
characteristics, familial risk factors for psychopathology, and
other parameters (including age, sex, alcohol or substance use,
and childhood trauma [110]). The Client Service Receipt
Inventory [87] will be used to record patients’ contacts with
mental health services, monitor variation in the delivery of TAU,
and model economic outcomes for a definitive trial. The
Working Alliance Inventory [111,112] will be used to assess
the relationship between practitioners and patients.
Sample Size
A formal sample size calculation is not essential for this
exploratory trial, which primarily seeks to establish feasibility,
effects on candidate mechanisms, and initial signals of efficacy.
In planning, we aimed to determine the sample size in such a
way as to establish the feasibility of the methodology for
conducting an RCT and delivering the EMIcompass intervention
to youth with early mental health problems and initial signals
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of the efficacy of EMIcompass in reducing psychological
distress as a candidate primary outcome (see Statistical Analysis
Plan [113] for further detail) as a basis for a future definitive
trial. For the latter, previous studies of third-wave CBT [72,114],
including compassion-focused interventions [68,77], suggest
that these types of interventions may yield clinically meaningful
reductions in psychological distress of moderate to large effect
size. This is consistent with the initial findings from an
uncontrolled phase I pilot study [53]. However, even if the effect
size for the main effect of condition on psychological distress
(primary outcome) in this exploratory RCT is small, a power
simulation in the R environment indicated that a sample size of
N=80 participants (40/40, 50% experimental, 40/40, 50% control
condition) would be sufficient to detect a small effect size of
0.3 across the postintervention 4-week follow-up with a power
of 81% when testing at α=.05 for the effect of condition
(experimental vs control condition) on psychological distress
using linear mixed modeling, which will be tested using a
Wald-type test of no difference between the two conditions
across both time points against the two-sided alternative
hypothesis that the conditions are, on average, different across
the two follow-up time points (given the exploratory nature of
this trial), while controlling for baseline psychological distress
and group status. At the 4-week follow-up, we expect an attrition
rate of 15%, resulting in a loss to follow-up of approximately
6 individuals per condition on average (Figure 1). Therefore,
we will randomize a total of 92 participants at baseline, leaving
80 participants at follow-up to detect a small effect size of 0.3
at this time point. This sample size is also sufficient to test the
criteria for establishing feasibility. Simulation studies on power
and accuracy for multilevel mediation models with continuous
variables [115] and our recently completed multilevel moderated
mediation analysis of EMA data [42] suggest very little bias in
parameter estimates with samples of this size (and 40 repeated
measures, on average, per participant).
Randomization and Blinding
Participants will be randomized at a 50:50 ratio to the
experimental or control condition at the level of the individual
participant after completion of the baseline assessment. Block
randomization in blocks of four will be performed by an
independent research assistant through a computer-generated
sequence, with stratification for the three stages (ie, stages 1a,
1b, and 2). The assessors will be blind to the allocation of
participants when assessing outcomes at postintervention and
follow-up. Any data specific to the intervention group (eg,
clinical feasibility) will be stored in a separate database. Breaks
in masking will be documented, and another (blinded) researcher
will repeat the assessment to maintain masking.
Assessment of Safety
Serious adverse events (SAEs) will be monitored throughout
the entire study period and reported to the accredited Medical
Ethics Review Committee, the Data Monitoring and Ethics
Committee (DMEC), and, where required, the Trial Steering
Committee (TSC). SAEs are any serious incidents that result
in death, persistent or significant disability or incapacity that
require hospitalization, or life-threatening situations. SAEs are
not expected to occur as a result of the intervention. If there are
doubts about safety or ethical concerns, the TSC will terminate
the trial. The DMEC will advise on safety and ethical concerns,
monitor evidence for harm by the intervention (eg, SAEs) in
the experimental condition, and review whether these events
are in line with expectations. If deemed necessary, the DMEC
can recommend to the principal investigator (PI) and TSC for
interim analyses to be conducted and the trial to be terminated
prematurely.
Statistical Analysis
The primary objective of this exploratory RCT is to establish
the feasibility of the trial methodology and intervention delivery
and initial signals of efficacy on the candidate primary outcome
(ie, psychological distress) as a basis for a future definitive trial.
In addition, this trial seeks to obtain parameter estimates (95%
CI) for the effects on primary and secondary candidate
mechanisms and candidate secondary outcomes. A detailed
Statistical Analysis Plan [113] has been agreed with the DMEC
and the TSC and has been preregistered and published on the
Open Science Framework. It was registered while collecting
the data before study completion and accessing the locked
database. Descriptive statistics will be used, and CIs will be
constructed as appropriate to compute basic sample
characteristics and address the primary aim of establishing the
feasibility of the trial methodology and intervention delivery
based on the criteria described above and in further detail in the
Statistical Analysis Plan using three categories (in line with a
traffic light system): (1) feasibility fully established (green), (2)
feasibility established, but study procedures need to be modified
(yellow), and (3) feasibility not established (red) [113]. The
analysis of candidate mechanisms and initial signals of efficacy
has been described in detail in the Statistical Analysis Plan [113]
and will be an intention-to-treat analysis or an available case
analysis following intention-to-treat principles, with data from
all participants entered into the analysis, including those who
have low adherence to or who will drop out from the
intervention. We will make every effort to assess all participants
at postintervention and 4-week follow-up. Linear mixed
modeling in Stata 16 will be used to compare candidate
mechanisms and outcomes between experimental and control
conditions at postintervention and 4-week follow-up. The
primary candidate outcome of psychological distress measured
at postintervention and 4-week follow-up will be entered as the
dependent variable and psychological distress measured at
baseline, group status (3-level factor), time (2-level factor), and
condition (2-level factor) as independent variables. The main
effect of condition on psychological distress will be
parameterized so that it reflects the difference between the two
conditions at the two follow-up time points (ie, postintervention
and 4-week follow-up), which will be tested (at α=.05) by a
Wald-type test with df=1, which tests the joint null hypothesis
of no difference at both follow-up time points against the
alternative hypothesis that there is, on average, a difference
across the two follow-up time points. In addition, given the
exploratory nature of this trial, with the main goal of establishing
feasibility and obtaining parameter estimates for a future
definitive RCT, 95% CI for the two time-specific contrasts of
a time×condition interaction term will be inspected to obtain
estimates for the differences across conditions at each of the
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two time points, with a time × condition interaction and a
baseline psychological distress×time interaction added as
independent variables to the previous model. Within-subject
clustering of repeated measures (postintervention and 4-week
follow-up) will be taken into account by including a level-2
random intercept and allowing the models’ level-1 residuals to
be correlated with a completely unstructured error
variance-covariance matrix. The model will be fitted using
restricted maximum likelihood estimation. The analysis of
secondary candidate outcomes and primary and secondary
candidate mechanisms will, in principle, follow the same steps,
focusing on 95% CIs (rather than P values at α<.05). Multilevel
moderated mediation analysis of EMA data will be used to
explore whether the effects of condition on primary (ie,
psychotic, manic, anxiety, or depressive) symptoms are mediated
via stress reactivity, threat anticipation, negative affective
appraisals, and interpersonal sensitivity [42]. As participants
will be randomly assigned to experimental and control
conditions, no differences across conditions are expected in
other study parameters (sociodemographic characteristics,
alcohol or substance use, and childhood trauma). No statistical
tests will be performed on these study parameters at baseline.
Results
Overview
The trial is ongoing. It started recruitment on July 15, 2019, and
the first enrollment was conducted in August 2019. We are
currently working with trial protocol version 5 (June 24, 2020).
The last changes to the protocol were related to adaptations
because of the COVID-19 pandemic, such as introducing the
option of using video conferencing systems. As of May 2021,
enrollment and randomization were completed (n=92
participants). Assessment of outcomes at postintervention and
follow-up is still ongoing, with the last assessment for the last
participant being scheduled for August 2021. Data will then be
entered, checked, and the database locked (by September 2021).
We expect results to be published in 2022.
Research Governance
The CIMH is the trial sponsor. The study has received ethical
approval by the local ethics committee (EC) of the Medical
Faculty Mannheim, Heidelberg University (2017-602N-MA).
Amendments to the study protocol will be submitted to the EC
and sent to the DMEC, TSC, and study sponsor. The trial is
registered at the clinical trial register, and changes to the
protocol will be updated. Deviations from the protocol will be
documented in the study folder using a breach report form and
will be reported to the TSC. The trial does not involve the
collection or storage of biological samples. All data will be
handled confidentially and will be coded using a number
according to the order of study entry. Data will be securely
stored in line with the European General Data Protection
Regulation. Personal data will be kept separately from
pseudonymized data. The PI has overall responsibility for the
trial. The trial research team will meet regularly and will be
chaired by the PI. It will manage the day-to-day running of the
study, monitor the progress of the trial (ie, recruitment and
assessment), and oversee the preparation of presentations and
reports to EC, TSC, and DMEC. The TSC will meet biannually
and provide independent overall supervision, monitor the
progress of the trial (eg, recruitment, data completion rates, and
adherence to the protocol), and approve the protocol and any
amendments. The DMEC will meet at least once per year, advise
on ethical or safety concerns, monitor SAEs and other evidence
of intervention harm and whether this is in line with
expectations. If deemed necessary, the DMEC can recommend
that the PI and TSC are granted access to all trial data, to
perform interim analyses and to terminate the trial prematurely.
Discussion
Transdiagnostic mechanisms implicated in the development of
severe mental disorders are important targets for prevention and
early intervention. Ecological translation of compassion-focused
intervention components to individuals’ daily lives through an
EMI offers new avenues for tangible prevention strategies
delivering real-world and real-time interventions that are easily
accessible by youth [36]. Findings from a recent, nationally
representative survey suggest that psychological distress, social
isolation, lack of company, and worrying during the COVID-19
pandemic were highly prevalent in youth and, interestingly,
associated with the current use of and a positive attitude toward
digital interventions [33]. EMIs are also amenable to enhancing
access to mental health services for youth depending on their
needs and preferences, for instance, by delivering low-threshold
interventions by frontline mental health staff [116-118] as a
component that can be rolled out across adolescent and adult
mental health services and link in with what is urgently needed,
that is, a wider youth mental health reform that aims to provide
seamless coverage of mental health care with smooth transitions
from adolescence to mature adulthood at an age of
approximately 25 years [20]. Furthermore, EMIs allow for
investigating the strength of the evidence in support of several
causal criteria (ie, association, temporality, sole plausibility,
and ecological validity) as part of the ecological interventionist
causal model approach that targets candidate underlying
psychological mechanisms in daily life to achieve sustainable
change under real-world conditions [27]. However, robust,
trial-based evidence on EMIs and other mHealth interventions
remain very limited [26,27,29,36,116,119]. A key next step is
to examine the efficacy of youth-friendly, accessible, interactive,
real-time interventions targeting candidate mechanisms
underlying the transdiagnostic phenotype of psychosis, mania,
depression and anxiety and thereby, help preventing adverse
outcomes later in life. While, in the current study, we use EMA
items that have been previously used and validated to measure
moment-to-moment variation in stress/negative affect, with
considerable within-person variability having been observed
for these items in several EMA studies [43,89,120],
inter-individual differences in within-person variability as well
as general response tendencies may influence the number of
triggered EMI tasks and hence, further research is needed to
optimize and personalize the assignment of EMI components,
eg, by using methods of artificial intelligence, recurrent neural
networks (RNNs) in particular [121]. For example, we currently
aim to apply recurrent neural networks in an ongoing study of
personalized digital mental health promotion and prevention in
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youth [33]. In addition, clinical staging models of severe mental
disorders require further scrutiny, including heterogeneity in
phenomenology, course, and outcome within individual stages
[5,122,123].
The present exploratory RCT is the first to establish feasibility,
evidence on underlying mechanisms, and preliminary signals
of efficacy of a compassion-focused, hybrid EMI for reducing
stress reactivity (EMIcompass) in youth at different clinical
stages. Preliminary evidence from a pilot study of the
EMIcompass intervention in help-seeking youth showed
reductions in clinical symptoms and stress reactivity [53]. If
this exploratory trial is successful, a confirmatory RCT will be
warranted. Overall, our approach has a scalable potential to
prevent the transition of early mental health problems to severe
and enduring mental disorders not only in individuals at risk of
developing psychosis but transdiagnostically and across clinical
stages and, thereby, significantly advance preventive
interventions in youth mental health provision.
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